Debut Plus

196.91

-3.67 -1.83%

As of 09 Sept 2026 · delayed

NSE Listed

Sun Pharma Advanced Research Company Ltd. (SPARC)

Volume: 5,19,851Avg Vol 1W: 8,56,055.2Avg Vol 1M: 8,94,449.7552W Range:108289
Key Ratios
Checked 8h ago
Market Cap₹6,509 Cr
Current Price₹196.91
Previous Close₹200.58
High / Low (52w)₹289 / ₹108
Volume5,19,851
Avg Vol (1W)8,56,055.2
Avg Vol (1M)8,94,449.75
Stock P/E-14.03
Book Value₹-6.68
Dividend Yield
ROE0%
ROA
Revenue (TTM)₹74 Cr
Revenue Growth
Profit Margin
Total Debt₹100 Cr
Shares Outstanding
Face Value₹1
EPS (TTM)₹-10.55
P/B-22.16
Debt / Equity0
50 DMA₹217.82
200 DMA₹171.74
Day change-1.83%
Price Chart
196.91 36.80% · 1Y
27810912.2Cr
2025-09-10
2026-09-09

20-day avg volume: 8.9L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 66% YoY.
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹13 Cr₹15 Cr₹27 Cr₹10 Cr₹8 Cr₹8 Cr₹1,853 Cr₹40 Cr
EBITDA₹-106 Cr₹-77 Cr₹-56 Cr₹-46 Cr₹-68 Cr₹-59 Cr₹1,773 Cr₹-13 Cr
Net Profit₹-107 Cr₹-80 Cr₹-60 Cr₹-52 Cr₹-76 Cr₹-80 Cr₹1,761 Cr₹-21 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹27 Cr₹74 Cr₹10 Cr₹8 Cr₹8 Cr₹1,853 Cr₹1,890 Cr₹40 Cr
EBITDA₹-56 Cr₹-334 Cr₹-46 Cr₹-68 Cr₹-59 Cr₹1,772 Cr₹1,600 Cr₹-13 Cr
Net Profit₹-61 Cr₹-343 Cr₹-52 Cr₹-76 Cr₹-81 Cr₹1,761 Cr₹1,553 Cr₹-21 Cr
EPS-10.5547.86
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹273 Cr₹230 Cr₹280 Cr₹830 Cr₹515 Cr₹336 Cr₹2,171 Cr
Total Liabilities₹291 Cr₹398 Cr₹249 Cr₹317 Cr₹389 Cr₹552 Cr₹832 Cr
Equity₹-19 Cr₹-168 Cr₹31 Cr₹513 Cr₹126 Cr₹-217 Cr₹1,339 Cr
Total Debt₹6 Cr₹113 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-150 Cr₹-213 Cr₹-74 Cr₹-425 Cr₹-369 Cr₹-270 Cr
Investing₹2 Cr₹-29 Cr₹-548 Cr₹392 Cr₹158 Cr₹-23 Cr
Financing₹159 Cr₹229 Cr₹617 Cr₹42 Cr₹199 Cr₹261 Cr
Free Cash Flow₹-150 Cr₹-213 Cr₹-74 Cr₹-425 Cr₹-369 Cr₹-270 Cr
Shareholding
Promoter 65.67% Institutions 4% Public 30.33%
Efficiency & Working Capital
ROCE80.9%
Interest Coverage46.5
Dividend Payout
Debtor Days2 d
Inventory Days0 d
Payable Days19 d
Cash Conversion Cycle-17 d
Working Capital Days2 d
Shareholding Details

As of 2026-06-30

Promoter65.7%
FII3.9%
DII0.1%
Institutions4%
Public30.3%
Promoter Pledge0%
No. of Shareholders1,41,957
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026May 2026May 2026Jun 2026
Promoters65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%65.7%
FIIs3.2%2.6%2.1%2.2%1.4%1.5%1.8%2%2%2.5%2.5%3.9%
DIIs0.8%0.2%0.2%0.6%1.1%1%1%0.8%0.9%0.1%0.1%0.1%
Public30.3%31.5%32%31.5%31.8%31.9%31.5%31.5%31.4%31.8%31.8%30.3%
Promoter Pledge2.8%2.8%2.8%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,02,7431,25,1841,28,2051,31,0341,42,8641,40,7241,36,9971,44,8101,40,6251,37,5381,37,5381,41,957
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Shanghvi Finance Private LimitedShareholding of Promoter and Promoter Group42.3%13.72 Cr
Dilip.s.shanghviShareholding of Promoter and Promoter Group19.1%6.18 Cr
Sun Pharmaceutical Industries Key Employees Benefit TrustPublic Shareholding3.2%1.03 Cr
Lakshdeep Investments & Finance (p) Ltd.Public Shareholding1.9%60,33,835
Aditya Medisales LimitedShareholding of Promoter and Promoter Group1.5%48,88,126
Raksha Sudhir ValiaShareholding of Promoter and Promoter Group1.3%41,45,231
Paresh Mohanlal ParekhPublic Shareholding1.1%36,51,837
Vijay Mohanlal ParekhPublic Shareholding1.1%36,65,304
Enam Securities Private LimitedPublic Shareholding1%33,70,786
Sudhir Vrundavandas ValiaShareholding of Promoter and Promoter Group0.6%18,33,951
Unimed Investments LimitedShareholding of Promoter and Promoter Group0.4%12,67,963
Vibha Dilip ShanghviShareholding of Promoter and Promoter Group0.3%10,63,236
Aalok Dilip ShanghviShareholding of Promoter and Promoter Group0.1%3,50,162
Vidhi Dilip ShanghviShareholding of Promoter and Promoter Group0.1%3,44,081
Shanghvi Family & Friends Benefit TrustShareholding of Promoter and Promoter Group0.1%1,54,922
Kumud Shantilal ShanghviShareholding of Promoter and Promoter Group0%38,795
Krishna Vrundavandas ValiaShareholding of Promoter and Promoter Group0%0
Flamboyawer Finance Private LimitedShareholding of Promoter and Promoter Group0%2,543
Shanghvi Universal Private LimitedShareholding of Promoter and Promoter Group0%1,887
Sun Petro Private LimitedShareholding of Promoter and Promoter Group0%1,751
Board of Directors
NameDesignationYear
Dilip S ShanghviChairman & Non Executive Dir.2026
Vidhi ShanghviNon-Exec & Non-Independent Dir2026
T RajamannarNon Executive Director2026
Robert SpiegelIndependent Non Exe. Director2026
Venkateswarlu JastiIndependent Non Exe. Director2026
Rekha WarriarIndependent Non Exe. Director2026
Kajal DamaniaCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals Research & Developm₹0 Cr
Segments — Geography
RegionRevenueShare
Within India₹38 Cr97.2%
Outside India₹1 Cr2.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1433232
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-10Board Meetings
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20263006-114-105
2026000000
20263006-153-144
Insider / Designated-Person Trades

10 recent disclosure(s)

SUDHIR VALIAPledge · 18,00,000
RAKSHA VALIAPledge · 22,00,000
Dilip S. ShanghviAcquisition · 2,52,80,899
RAKSHA VALIAPledge · 19,00,000
Raksha ValiaPledge · 30,80,000
Raksha ValiaPledge · 10,00,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Pref. Allotment19/05/2026 · 3,85,10,000
Company Information
Incorporated2006
ChairmanDilip S Shanghvi
AuditorS R B C & Co LLP
Investor Email[email protected]
🌐 www.sparc.life

📍 Sun Pharma Advanced Res Centre, Akota Road Akota, Vadodara, Gujarat, 390020

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search